Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE)

Active
DARPA-PA-27-01Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance

VA

Set-Aside

NONE

Documents

7

Attachment C: Cost Proposal Spreadsheet - HUBBLE

XLSX, High priority: read this first9 pages · specifications
High

Attachment D: Schedule Milestone and Payments

XLSX, High priority: read this first3 pages · specifications
High

Attachment F: Risk Matrix - HUBBLE

PPTX, High priority: read this first3 pages · specifications
High

DARPA Model Other Transaction (OT) Agreement for Research - HUBBLE

DOCX, High priority: read this first42 pages · contract-document
High

DARPA-PA-27-01 HUBBLE Abstract Template

DOCX, High priority: read this first3 pages · specifications
High

DARPA-PA-27-01: HUBBLE Program Announcement

PDF, High priority: read this first23 pages · rfp
High

DARPA-PA-27-01 HUBBLE Task Description Document (Attachment E)

DOCX, High priority: read this firstsow
High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Advanced Research Projects Agcy
Contacts1 person available
OfficeARLINGTON, VA, 222032114, USA
Office AddressARLINGTON, VA, 222032114, USA
Contacts
Dr. Abhishek Singharoy DARPA/BTO

Full Description

Show more
The Defense Advanced Research Projects Agency (DARPA) is soliciting proposals to develop an in-silico capability for mapping all protein-protein interactions. Utility of this capability will be demonstrated in identifying novel diagnostic and therapeutic targets within the interaction space underlying including traumatic brain injury.

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Grant
Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)
Solicitation # RFA-RM-27-024
The National Institutes of Health, administered by the National Institute of Dental and Craniofacial Research, is soliciting applications for Pilot Projects to Enhance the Human Virome Program under solicitation RFA-RM-27-024. This initiative seeks to support small pilot projects that characterize the healthy human virome and develop tools, models, and methods to study its composition and influence on health and disease. Eligible applicants include small businesses and other for-profit organizations, with a strong encouragement for those outside the current Human Virome Program consortium to apply. The program intends to commit approximately 2 million dollars in FY2027, with individual award direct costs capped at 100,000 dollars per year. Applications are due by November 10, 2026, for a potential July 2027 start date, or October 22, 2027, for a potential July 2028 start date. Awards are granted based on scientific and technical merit evaluated through the NIH peer review system, focusing on the importance of the research, rigor and feasibility of the approach, and the expertise of the investigators and their environment. Successful projects must produce unbiased, reproducible data and validated tools while adhering to strict regulatory standards, including 45 CFR Part 46 for human subject protections and various federal cybersecurity requirements, such as multifactor authentication and 48-hour incident notification. Applicants must maintain active registrations in the System for Award Management, eRA Commons, and Grants.gov, and all Principal Investigators must be registered with ORCID. Compliance with intellectual property management under Executive Order 10096 and federal regulations 42 CFR Part 52 and 2 CFR Part 200 is mandatory.
National Institutes Of Health

POSTED

1 day ago

DEADLINE

in about 1 month
View Details
NAICS: 541714
Federal
Pre-solicitation Notice: On-Ramp for the Department of Defense OMNIBUS IV Multiple-Award Contract
Solicitation # HT942626RE002
The Defense Health Agency Contracting Activity is issuing a pre-solicitation notice for an on-ramp to the OMNIBUS IV Multiple Award, Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle. This initiative aims to expand the pool of eligible contractors providing military medical research and development services, including laboratory and technical support, regulatory process expertise, and translational science services. The eventual Request for Proposal will be set aside exclusively for small businesses certified under the Small Business Administration 8(a) Program. Due to the need to implement recent FAR Overhaul guidance, the anticipated posting timeframe for the solicitation has been extended to late September 2026. The OMNIBUS IV vehicle operates with a base ordering period from June 20, 2022, through June 19, 2027, and an option ordering period extending to June 19, 2032. It features a cumulative ceiling of 10 billion dollars, with over 630 million dollars already awarded across 55 task orders to various end users, including the Naval Supply Systems Command and the Uniformed Services University of the Health Sciences. New awards from this on-ramp will align with the existing unrestricted vehicle. Prospective offerors must be registered in SAM.gov and will be required to submit proposals through the Procurement Integrated Enterprise Environment solicitation module once the formal RFP is released.
Defense Health Agency

POSTED

7 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Grant
Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)
Solicitation # RFA-AI-28-031
The National Institutes of Health, under the Department of Health and Human Services, is soliciting applications for the Centers for Structural Biology of HIV and Other Infectious Diseases (RFA-AI-28-031). This funding opportunity seeks to establish multidisciplinary consortia of structural biologists and microbiologists to solve complex biological structures necessary for the prevention, treatment, and cure of HIV and other infectious diseases. The program emphasizes the use of advanced experimental approaches, including hybrid imaging, artificial intelligence, protein design, and dynamic computational modeling. NIAID intends to commit 33 million dollars in FY 2028, with individual application budgets not expected to exceed 3.5 million dollars in direct costs. The program is structured around a cooperative agreement requiring several functional components: an Administrative Core, a Workforce Development Core, two to four Scientific Cores, and three Research Projects. A Service and Resource Core is required for Infectious Disease Centers but prohibited for HIV Centers. Applications will be evaluated based on scientific and technical merit, relevance to program priorities, and the availability of funds, with a specific focus on multidisciplinary integration and innovation. Clinical trials are not allowed under this notice. Applicants must maintain active registrations in the System for Award Management and eRA Commons, and all Principal Investigators must have a linked ORCID ID. Required documentation includes a Data Management and Sharing Plan, a Resource Sharing Plan, and letters of institutional support. Strict cybersecurity requirements are in place, including multifactor authentication and a 48-hour incident notification window. The response deadline for this solicitation is May 28, 2027.
National Institutes Of Health

POSTED

8 days ago

DEADLINE

in 8 months
View Details
NAICS: 541714
Federal
Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories
Solicitation # 75N98026R00175
The National Institutes of Health is issuing a Sources Sought Notice to identify qualified research and development firms, small businesses, and subcontractors capable of providing biobanking, laboratory analytics, and informatics services for NIH biorepositories starting in fiscal year 2028. The primary objective is to support the operation and potential consolidation of repositories, specifically including the NIDA Center for Genetic Studies and the NIH Brain Development Cohorts Biobank. This is a market research effort to determine the availability of technically capable sources and to inform the government's decision on the appropriate acquisition method and potential small business set-asides. The required scope of work involves the secure storage and tracking of at least 3.5 million biospecimens, comprehensive data curation and management using auditable LIMS, and advanced laboratory capabilities such as high-throughput sequencing and CRISPR/Cas9 gene editing. Additionally, the contractor must provide informatics support to develop and maintain web portals, APIs, and secure cyberinfrastructure compliant with FISMA standards. Interested parties must submit a detailed capability statement, including experience, personnel qualifications, and facility descriptions, to the designated contract specialists by October 20, 2026.
National Institutes Of Health Nida

POSTED

8 days ago

DEADLINE

in 11 days
View Details
NAICS: 541714
Federal
Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
Solicitation # ARPA-H-SOL-26-164
The Advanced Research Projects Agency for Health (ARPA-H) is soliciting proposals for the Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) program under solicitation ARPA-H-SOL-26-164. This five-year initiative aims to create a reusable blueprint for future adaptive seamless platform trials through the integration of three technical areas: a Phaseless Design Engine, Continuous Inference, and Agentic Operations. The program is divided into two stages, with Stage I focusing on capability buildout, FDA engagement, and the onboarding of at least three intervention arms over 24 months, followed by a 36-month Stage II dedicated to validation and deployment. A critical go/no-go milestone is obtaining FDA authorization for the platform Master Protocol IND and at least one investigational arm by the end of Stage I. The government intends to make multiple awards via Other Transaction Agreements to proposers offering the most advantageous solutions based on innovation, feasibility, and technical merit at reasonable prices. Eligible entities must possess a Unique Entity Identifier and active SAM registration. Proposals are submitted in a phased approach, beginning with a Solution Summary and potentially progressing to a Solution Pitch package. Performance will be measured by the successful integration of the three technical areas and the achievement of specific program metrics. All work must adhere to ICH E6(R3) Good Clinical Practice and strict regulatory standards to ensure inspection readiness and participant safety.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

9 days ago

DEADLINE

in about 2 months
View Details
NAICS: 541714
Federal
SURPASS Webinar and Proposers' Day Information
Solicitation # ARPA-H-SN-26-164
The Advanced Research Projects Agency for Health (ARPA-H), under the Department of Health and Human Services, has issued Special Notice ARPA-H-SN-26-164 regarding the Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) program. This initiative aims to modernize clinical research by transforming drug and biologics development into a continuous learning system, with the goal of reducing development timelines from over ten years to fewer than four. The program focuses on creating disease-specific multi-arm platforms that integrate AI-powered operational infrastructure, in silico modeling, and advanced adaptive designs to enable a seamless transition from first-in-patient evaluation to confirmatory assessment. Key outputs include a reusable blueprint for future trials, simulation-based design tools, and continuous inference and adaptation approaches, all aligning with the goals of HHS Operation TrialBlazer. This specific notice serves as an informational announcement and does not constitute a formal solicitation for proposals. It invites interested parties to an informational webinar on October 15, 2026, and a two-day Proposers Day on November 6 and 9, 2026. Potential participants may optionally submit teaming profiles, lightning talk slides, and posters to showcase their expertise. Full program details and formal solicitation requirements are located under solicitation ARPA-H-SOL-26-164. All inquiries are directed to the SURPASS team, with Daria Fedyukina serving as the Technical Point of Contact.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

9 days ago

DEADLINE

in 3 days
View Details

More opportunities from Department Of Defense → Defense Advanced Research Projects Agcy

Same awarding agency

NAICS: 541715
New
Federal
Atomically Precise Molecules (APM)
Solicitation # DARPA-PS-26-141
The Defense Advanced Research Projects Agency (DARPA) Multi X Office is soliciting innovative proposals under solicitation DARPA-PS-26-141 for the Atomically Precise Molecules (APM) program. The objective is to develop new synthesis techniques for programmable precision polymers (PPPs) and nonlinear optical (NLO) materials to overcome performance gaps in optical communications and LiDAR. The program requires the development of scalable materials that culminate in a prototype demonstration integrated into a government-provided electro-optic modulator. Research focusing solely on inorganic materials or incremental improvements to the existing state of the art is specifically excluded. Awards will be issued as Other Transaction (OT) for Prototype Agreements under 10 U.S.C. § 4022. The performance period is milestone-based, featuring key deliverables such as an initial development plan, CMMC Level 2 operational compliance, and a final Phase II prototype demonstration by month 35. Proposals are evaluated based on technical approach, relevance to the DARPA mission, budget realism, and the capability to transition technology to military or industrial communities. Submissions must be made via the Broad Agency Announcement Tool (BAAT), with a final proposal deadline of December 18, 2026. Performers must adhere to strict cybersecurity requirements, including CMMC compliance and the protection of Controlled Unclassified Information (CUI).
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 9 hours ago

DEADLINE

in 2 months
View Details
NAICS: 541715
New
Grant
Information Processing Techniques Office Office-Wide
Solicitation # HR001126S0011
The Defense Advanced Research Projects Agency Information Processing Techniques Office issued Broad Agency Announcement HR001126S0011 to solicit revolutionary research ideas that provide decisive computational advantages for national security. The scope focuses on three primary thrust areas: AI Innovation and Execution for energy-efficient and trustworthy systems at the network edge, Inherent Security and Privacy to create adaptable and secure cyberspace tools, and Resilient Megasystems to model and protect complex interconnected systems like power grids. This open solicitation is available to all responsible sources, including U.S. and non-U.S. organizations, and may result in awards through procurement contracts, grants, cooperative agreements, or Other Transaction agreements. Submissions follow a two-step evaluation process beginning with a mandatory technical conformance review of a five-page abstract, followed by a comprehensive evaluation for invited proposers. Key evaluation criteria include overall scientific and technical merit, potential contribution to the DARPA mission, plans for implementing resilient software using formal methods, and cost realism. Proposers must possess an active SAM.gov Unique Entity Identifier and meet CMMC Level 2 self-assessment requirements for protecting Controlled Unclassified Information. Due to the nature of the research, strict protocols are in place for classified submissions, and DARPA will conduct risk-based security reviews of all senior key personnel to identify potential foreign influence.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

4 days ago

DEADLINE

in 9 months
View Details
NAICS: 541715
Federal
RFI for Next Generation Hypersonic Cruise Missiles
Solicitation # DARPA-SN-26-93
The Defense Advanced Research Projects Agency (DARPA) Tactical Technology Office has issued Request for Information DARPA-SN-26-93 to gather industry input for the development of a Next Generation Hypersonic Cruise Missile (NGHCM). This sources-sought action is intended to refine technical requirements, validate programmatic assumptions, and inform the acquisition strategy for a potential future competitive solicitation. DARPA is specifically seeking revolutionary concepts that provide significant leaps in range, speed, and altitude while prioritizing affordability and manufacturability through a Design for Manufacturing and Assembly philosophy. The RFI focuses on three primary areas: trade space exploration and concept development, evaluation of critical technologies such as high-energy density fuels and thermal management, and innovative test and evaluation technologies including novel range safety architectures. Interested parties must submit responses in English by November 6, 2026, ensuring they do not exceed fifteen single-sided pages using 11-point font. Submissions should include a technical description, a bibliography, and an optional graphic overview slide. Strict security protocols are in place for the handling and marking of proprietary information, Controlled Unclassified Information, and classified data, with requirements for separate transmission of classified materials. This RFI is for planning purposes only and does not constitute a formal solicitation; therefore, no reimbursement for response costs will be provided, and no formal evaluation factors or contract values have been established at this time.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

9 days ago

DEADLINE

in 28 days
View Details
NAICS: 541715
Federal
Resilient
Solicitation # DARPA-PA-25-07-04
The Defense Advanced Research Projects Agency (DARPA) Defense Sciences Office is soliciting innovative basic or applied research through the Resilient Disruption Opportunity (DARPA-PA-25-07-04). The program aims to develop a new methodology for accelerated materials testing and prediction for concrete, utilizing physics-informed scalability models and transportable material accelerators to predict macro-scale structural lifetimes in weeks rather than decades. The objective is to move beyond traditional laboratory proxies and identify specific rate-limiting kinetic equations, such as modified Arrhenius or Nernst-Planck, rather than relying on generic machine learning or existing ASTM tests. Awards will be issued as Other Transaction for Prototype Agreements with a total potential value of $2,000,000, split equally between a 12-month base Phase 1 and a 12-month option Phase 2. Performance is measured by strict metrics, including material acceleration factors of over 100x in Phase 1 and 1,000x in Phase 2, with predictive accuracy for time to failure within 10 to 25 percent of real-world data. The program involves 13 fixed payable milestones, with payments processed through the Wide Area Workflow system. Proposers must submit a technical proposal and a price proposal via the DARPA BAA Portal. Key requirements include a mandatory abstract, a data and sourcing narrative, and a signed data sharing agreement. Prime proposers must maintain current Cybersecurity Maturity Model Certification (CMMC) status in the Supplier Performance Risk System. Additionally, any proposals involving University Affiliated Research Centers must include an organizational conflict of interest mitigation plan.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

11 days ago

DEADLINE

in 10 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS